Dicerna Pharmaceuticals Inc Business Finance Contracts & Agreements

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2016 Inducement Plan (Filed With SEC on November 5, 2020)

Amendment to Indenture of Lease by and between the Company and HCP/King 75 Hayden LLC, dated as of July 1, 2020 (Filed With SEC on August 6, 2020)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on January 13, 2020)

Form of Restricted Stock Unit Grant Notice (Filed With SEC on January 13, 2020)

Alexion Share Issuance Agreement, dated October 22, 2018, by and between the Company and Alexion Pharma Holding Unlimited Company (Filed With SEC on March 13, 2019)

Lilly Share Issuance Agreement, dated October 25, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on March 13, 2019)

Underwriting Agreement dated September 6, 2018 by and among Dicerna Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Leerink Partners LLC (Filed With SEC on September 11, 2018)

Share Issuance Agreement, dated as of April 20, 2018, between the Company and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 8, 2018)

Underwriting Agreement dated December 14, 2017 by and among Dicerna Pharmaceuticals, Inc., Stifel, Nicolaus & Company, Incorporated and Evercore Group L.L.C (Filed With SEC on December 18, 2017)

Form of Pre-Funded Warrant (Filed With SEC on December 18, 2017)

Form of First Amendment to Amended and Restated Registration Rights Agreement (Filed With SEC on December 18, 2017)

Letter Agreement entered into on December 13, 2017 by and between Dicerna Pharmaceuticals, Inc. and the holders of its redeemable convertible preferred stock (Filed With SEC on December 14, 2017)

REDEEMABLE CONVERTIBLE PREFERREDSTOCK PURCHASE AGREEMENT AMONG DICERNA PHARMACEUTICALS, INC. AND THE INVESTORS NAMED HEREIN DATED AS OF MARCH 30, 2017 (Filed With SEC on March 30, 2017)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND AMONG DICERNAPHARMACEUTICALS, INC. AND THE INVESTORS NAMED HEREIN DATED AS OF , 2017 (Filed With SEC on March 30, 2017)

DICERNA PHARMACEUTICALS, INC. 2016 INDUCEMENT PLAN TERMS AND CONDITIONS OF INDUCEMENT STOCK OPTION (Filed With SEC on March 10, 2016)

2,750,000 Shares DICERNA PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on May 22, 2015)

[] Shares of Common Stock DICERNA PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on January 28, 2014)

DICERNA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 28, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 28, 2014)

FORM OF DICERNA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 17, 2014)

FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 31, 2013)

WARRANT AGREEMENT To Purchase Shares of the Series A Preferred Stock of DICERNA PHARMACEUTICALS, INC. Dated as of March 25, 2009 (the Effective Date) (Filed With SEC on December 31, 2013)

WARRANT AGREEMENT To Purchase Shares of the Series B Preferred Stock of DICERNA PHARMACEUTICALS, INC. Dated as of July 6, 2011 (the Effective Date) (Filed With SEC on December 31, 2013)

FORM OF WARRANT TO PURCHASE PREFERRED STOCK (Filed With SEC on December 31, 2013)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED 2007 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (Filed With SEC on December 31, 2013)

FORM OF RESTRICTED STOCK AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

RESTRICTED STOCK AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 31, 2013)